Trial intelligence / Profile preview

Real-world pyrotinib in HER2-positive recurrent/metastatic breast cancer

ChiCTR2100050901Phase 4Recruiting

Sponsor

Tumor Hospital Affiliated to Guizhou Medical University

Start

Jun 2021

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1